Please login to the form below

Not currently logged in
Email:
Password:

Mission Therapeutics

This page shows the latest Mission Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Biomedical Catalyst funding 'must continue', says BIA

Biomedical Catalyst funding 'must continue', says BIA

macular degeneration (AMD), almost £3m for a Kings College London research team developing a T cell therapy for Crohn's disease and £1.9m for Cambridge start-up MISSION Therapeutics to

Latest news

  • GSK forms alliance with Epizyme

    The therapeutics would work by controlling the pathways of gene expression that contribute to diseases. ... Dr Robert Gould, CEO and president of Epizyme, said: "Epizyme's mission is to develop personalised therapeutics for genetically-defined patients

More from news
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Dr Colin Goddard appointed chairman at Mission Therapeutics Dr Colin Goddard appointed chairman at Mission Therapeutics

    Mission Therapeutics has appointed Dr Colin Goddard as its non-executive chairman, a role he will take up on January 1. ... Meanwhile, Mission Therapeutics' current chairman Dr Michael Moore will continue to sit on the firm's board and move into the

  • Crescendo Biologics appoints CFO Crescendo Biologics appoints CFO

    She joins from PsiOxus Therapeutics where she served as chief financial officer, and has also held a number of positions at Cytomyx Holdings, OrthoMimetics, and Mission Therapeutics. ... ambitious plans to create a high value pipeline of differentiated

  • Mission Therapeutics appoints new chief financial officer Mission Therapeutics appoints new chief financial officer

    David Luther joins with 25 years healthcare and pharmaceutical experience. Cambridge, UK-based Mission Therapeutics has appointed David Luther as chief financial officer. ... development. Dr Anker Lundemose, CEO of Mission Therapeutics, said: “David's

  • MISSION appoints Paul Wallace as chief business officer MISSION appoints Paul Wallace as chief business officer

    Cancer biotech MISSION Therapeutics has named Paul Wallace as chief business officer. ... The diversity of assets created is testimony to the rigour of MISSION's screening platform in this critically important, but hitherto difficult, area of drug

More from appointments
Approximately 1 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Makara Health

Independent healthcare communications agency with a passion to develop inspirational ideas that create sustained and positive change. Whether it is...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics